MarketPulse

tariff impact

6 articles
BenzingaBenzinga··Schall Law Firm

DSGR Faces Securities Fraud Investigation Over Conflicting Tariff Claims

Schall Law Firm investigates DSGR over conflicting tariff statements; stock fell 26.3% after Q4 2025 earnings.
DSGRstock declineshareholder litigation
BenzingaBenzinga··Prnewswire

McRae Industries Reports Q2 Earnings Decline Amid Tariff Headwinds

McRae Industries reports Q2 earnings decline to $0.42/share from $0.47 despite revenue growth, citing tariff pressures on margins and work boot sales softness.
MCRAAearnings reporttariff impact
The Motley FoolThe Motley Fool··Sarah Sidlow

Rice Hall James Bets $19.8M on Birkenstock Despite Year-Long Stock Slump

Rice Hall James acquires $19.8M stake in Birkenstock ($BIRK), betting on recovery despite 28% one-year stock decline amid tariff and currency headwinds.
ARLOBIRKinstitutional investmentstock underperformance
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Respiratory Testing Market Set to Surge 56% by 2032 as Diagnostics Innovation Accelerates

Global respiratory testing market projected to reach $9.32B by 2032, growing 6.50% annually from $5.99B in 2025, driven by molecular diagnostics and telemedicine innovations.
MDTABTRHHBYTMOPHG+3strategic partnershipssupply chain resilience
BenzingaBenzinga··Globe Newswire

Jakks Pacific Navigates Revenue Decline With Margin Expansion and Debt-Free Position

Jakks Pacific's 2025 revenue fell 17% to $570.7M due to tariffs, but margins hit 15-year highs at 32.4%. The debt-free company showed Q4 stabilization and returned $1/share to shareholders.
JAKKrevenue declineearnings report
The Motley FoolThe Motley Fool··Adam Levy

Nike Positioned for Recovery as New Leadership Executes Turnaround Plan

Nike's new CEO implements turnaround strategy amid China weakness and tariff headwinds. Strong North America/Europe growth and attractive valuation suggest recovery potential for patient investors.
NKEturnaround strategyearnings growth